Altre lingue GENinCode Plc

Azioni

GENI

GB00BL97B504

Tempo differito London S.E. Altri mercati azionari 13:04:34 13/05/2024			Variaz. 5gg	Var. 1 gen.
8,306 ^GBX	-13,70%		+5,47%	+58,21%

04/04	GENinCode Plc annuncia la pubblicazione da parte dell'American Journal of Preventive Cardiology di uno studio su 'Rischio poligenico e malattia cardiaca incidente in un'ampia coorte multietnica'.	CI
21/03	GENinCode afferma che ROCA è stato raccomandato come test di rischio di cancro ovarico in Inghilterra	AN

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	04/04
GENinCode says ROCA recommended as ovarian cancer risk test in England	21/03
GENinCode gets GBP57,000 in retail offer, well below maximum	28/12
GENinCode Raises GBP4 Million from Share Sale	28/12
GENinCode raises GBP4 million via placing and subscription	21/12
Genincode Plc Announces Placing And Subscription To Raise A Minimum Of £4.0 Mln	21/12
Aura eyes Tiris expansion; Kavango backs Pambili	29/11
GENinCode plc Agrees with the Food and Drug Administration to Create New Regulatory Class for Polygenic Risk scores and Transition Its Premarket Notification 510(K) Submission to A De Novo Pathway	29/11
EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up	20/09/23
Earnings Flash (GENI.L) GENINCODE Reports H1 Revenue GBP950,000	20/09/23
Earnings Flash (GENI.L) GENINCODE Posts H1 Loss GBX-3.33	20/09/23
GENinCode Plc Provides Revenue Guidance for the Second Half of 2023	20/09/23
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2023	20/09/23
Genincode plc Announces CARDIO inCode study on risk of incident Coronary Heart Disease	30/08/23
GENinCode Shares Rise on FDA Filing for Heart Disease Test Kit	16/08/23
GENinCode Submits Premarket Notification for US Commercial Distribution of Polygenic Test Kit	16/08/23
GENinCode plc Files its Premarket Notification with the Food and Drug Administration to Expand Its US Commercial Distribution of the Cardio InCode-Score Polygenic Test for the Risk Assessment and Prevention of Coronary Heart Disease	16/08/23
Certain Ordinary Shares of GENinCode Plc are subject to a Lock-Up Agreement Ending on 23-JUL-2023.	23/07/23
GENinCode Shares Rise Amid US Partnership with MedStar Health	19/07/23
GENinCode and MedStar collaborate on coronary heart disease testing	19/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue GENinCode Plc

Azioni

GENI

GB00BL97B504

Altre lingue

Filtri